mRNA Drug - Global and China Top Players Market Share and Ranking 2024
- Report Code : AMP2755288
- Published On: Jul, 2024
- Category : Healthcare & Pharma
- Pages : 130
-
According to Ample Market Research, the global market for mRNA Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China mRNA Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States mRNA Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
This report studies and analyses global mRNA Drug status and future trends, helps the client to determine the mRNA Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for mRNA Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global mRNA Drug market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global mRNA Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China mRNA Drug sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global mRNA Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global mRNA Drug key producing regions, capacity, production, and year over year growth
(6) mRNA Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Market segment by Type, covers
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe mRNA Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global mRNA Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China mRNA Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of mRNA Drug, percent & CAGR, 2019-2030
Chapter 5: mRNA Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
-
With tables and figures helping analyze worldwide mRNA Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 mRNA Drug Definition
1.2 Global mRNA Drug Market Size and Forecast
1.2.1 By Consumption Value, Global mRNA Drug Market Size,2019-2030
1.2.2 By Sales Quantity, Global mRNA Drug Market Size,2019-2030
1.2.3 Global mRNA Drug Average Selling Price (ASP),2019-20301.3 China mRNA Drug Market Size and Forecast
1.3.1 By Consumption Value, China mRNA Drug Market Size,2019-2030
1.3.2 By Sales Quantity, China mRNA Drug Market Size,2019-2030
1.3.3 China mRNA Drug Average Selling Price (ASP), 2019-20301.4 Share of China mRNA Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China mRNA Drug Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China mRNA Drug Market Share in Global, 2019-2030
1.4.3 mRNA Drug Market Size: China VS Global, 2019-20301.5 mRNA Drug Market Dynamics
1.5.1 mRNA Drug Market Drivers
1.5.2 mRNA Drug Market Restraints
1.5.3 mRNA Drug Industry Trends
1.5.4 mRNA Drug Industry Policy
2 Global Leading Manufacturers and Market Share2.1 By Revenue of mRNA Drug, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of mRNA Drug, Global Market Share by Company, 2019-2024
2.3 mRNA Drug Average Selling Price (ASP) by Company, 2019-2024
2.4 Global mRNA Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global mRNA Drug Concentration Ratio
2.6 Global mRNA Drug Mergers & Acquisitions, Expansion Plans
2.7 Global mRNA Drug Manufacturers Product Type
2.8 Head Office and mRNA Drug Production Site of Key Manufacturer
2.9 mRNA Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share3.1 By Revenue of mRNA Drug, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of mRNA Drug, China Market Share by Company, 2019-2024
3.3 China mRNA Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions4.1 Global mRNA Drug Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global mRNA Drug Capacity by Region
4.3 Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global mRNA Drug Production by Region, 2019-2030
4.5 Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis5.1 mRNA Drug Industry Chain
5.2 mRNA Drug Upstream Analysis
5.2.1 mRNA Drug Core Raw Materials
5.2.2 Main Manufacturers of mRNA Drug Core Raw Materials5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 mRNA Drug Production Mode
5.6 mRNA Drug Procurement Model
5.7 mRNA Drug Industry Sales Model and Sales Channels
5.7.1 mRNA Drug Sales Model
5.7.2 mRNA Drug Typical Distributors
6 Sights by Type6.1 mRNA Drug Classification
6.1.1 Preventive Vaccines
6.1.2 Therapeutic Vaccine
6.1.3 Therapeutic Drugs6.2 By Type, Global mRNA Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global mRNA Drug Consumption Value, 2019-2030
6.4 By Type, Global mRNA Drug Sales Quantity, 2019-2030
6.5 By Type, Global mRNA Drug Average Selling Price (ASP), 2019-2030
7 Sights by Application7.1 mRNA Drug Segment by Application
7.1.1 Hospital
7.1.2 Clinic7.2 By Application, Global mRNA Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global mRNA Drug Consumption Value, 2019-2030
7.4 By Application, Global mRNA Drug Sales Quantity, 2019-2030
7.5 By Application, Global mRNA Drug Price, 2019-2030
8 Sales Sights by Region8.1 By Region, Global mRNA Drug Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global mRNA Drug Consumption Value, 2019-2030
8.3 By Region, Global mRNA Drug Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America mRNA Drug & Forecasts, 2019-2030
8.4.2 By Country, North America mRNA Drug Market Size Market Share8.5 Europe
8.5.1 Europe mRNA Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe mRNA Drug Market Size Market Share8.6 Asia Pacific
8.6.1 Asia Pacific mRNA Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific mRNA Drug Market Size Market Share
8.7 South America
8.7.1 South America mRNA Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America mRNA Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level9.1 By Country, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global mRNA Drug Consumption Value, 2019-2030
9.3 By Country, Global mRNA Drug Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. mRNA Drug Market Size, 2019-2030
9.4.2 By Type, U.S. mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.4.3 By Application, U.S. mRNA Drug Sales Quantity Market Share, 2024 VS 20309.5 Europe
9.5.1 Europe mRNA Drug Market Size, 2019-2030
9.5.2 By Type, Europe mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.5.3 By Application, Europe mRNA Drug Sales Quantity Market Share, 2024 VS 20309.6 China
9.6.1 China mRNA Drug Market Size, 2019-2030
9.6.2 By Type, China mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.6.3 By Application, China mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan mRNA Drug Market Size, 2019-2030
9.7.2 By Type, Japan mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.7.3 By Application, Japan mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea mRNA Drug Market Size, 2019-2030
9.8.2 By Type, South Korea mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.8.3 By Application, South Korea mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia mRNA Drug Market Size, 2019-2030
9.9.2 By Type, Southeast Asia mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.9.3 By Application, Southeast Asia mRNA Drug Sales Quantity Market Share, 2024 VS 20309.10 India
9.10.1 India mRNA Drug Market Size, 2019-2030
9.10.2 By Type, India mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.10.3 By Application, India mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa mRNA Drug Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa mRNA Drug Sales Quantity Market Share, 2024 VS 2030
9.11.3 By Application, Middle East & Africa mRNA Drug Sales Quantity Market Share, 2024 VS 2030
10 Manufacturers Profile10.1 Moderna
10.1.1 Moderna Company Information, Head Office, Market Area, and Industry Position
10.1.2 Moderna mRNA Drug Models, Specifications, and Application
10.1.3 Moderna mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Moderna Company Profile and Main Business
10.1.5 Moderna Recent Developments10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Pfizer mRNA Drug Models, Specifications, and Application
10.2.3 Pfizer mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Information, Head Office, Market Area, and Industry Position
10.3.2 Zydus Cadila mRNA Drug Models, Specifications, and Application
10.3.3 Zydus Cadila mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Zydus Cadila Company Profile and Main Business
10.3.5 Zydus Cadila Recent Developments10.4 Fosun Pharma
10.4.1 Fosun Pharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Fosun Pharma mRNA Drug Models, Specifications, and Application
10.4.3 Fosun Pharma mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Fosun Pharma Company Profile and Main Business
10.4.5 Fosun Pharma Recent Developments10.5 CureVAC
10.5.1 CureVAC Company Information, Head Office, Market Area, and Industry Position
10.5.2 CureVAC mRNA Drug Models, Specifications, and Application
10.5.3 CureVAC mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 CureVAC Company Profile and Main Business
10.5.5 CureVAC Recent Developments10.6 Sri Lankan Microorganisms
10.6.1 Sri Lankan Microorganisms Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sri Lankan Microorganisms mRNA Drug Models, Specifications, and Application
10.6.3 Sri Lankan Microorganisms mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Sri Lankan Microorganisms Company Profile and Main Business
10.6.5 Sri Lankan Microorganisms Recent Developments
10.7 BioNtech
10.7.1 BioNtech Company Information, Head Office, Market Area, and Industry Position
10.7.2 BioNtech mRNA Drug Models, Specifications, and Application
10.7.3 BioNtech mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 BioNtech Company Profile and Main Business
10.7.5 BioNtech Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.8.2 AstraZeneca mRNA Drug Models, Specifications, and Application
10.8.3 AstraZeneca mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 AstraZeneca Company Profile and Main Business
10.8.5 AstraZeneca Recent Developments
10.9 Janssen
10.9.1 Janssen Company Information, Head Office, Market Area, and Industry Position
10.9.2 Janssen mRNA Drug Models, Specifications, and Application
10.9.3 Janssen mRNA Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Janssen Company Profile and Main Business
10.9.5 Janssen Recent Developments
11 Conclusion
12 Appendix12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources12.3 Market Estimation Model
12.4 Disclaimer
-
The mRNA Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the mRNA Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
The mRNA Drug Global and China Top Players Market study evaluates the year spans as follows: Historical year: 2018 to 2023; Base year: 2023; Forecast period**: 2024 to 2029 [** unless otherwise stated]
The mRNA Drug Global and China Top Players Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
During the forecast years, the mRNA Drug Global and China Top Players Market can thrive with a robust CAGR.
![bain](https://www.amplemarketreports.com/uploads/ca2683becb88940f3ccfe44c6a2dbefe.png)
![sorbwater](https://www.amplemarketreports.com/uploads/e7239c841bea43da0552492f33730483.jpg)
![pddynamic](https://www.amplemarketreports.com/uploads/3e3ea50c77a107645988b4db2adffc43.png)
![Gastite](https://www.amplemarketreports.com/uploads/47e137214a4479e0f06a24909987fd91.png)
![wayzn](https://www.amplemarketreports.com/uploads/c6fe613cdcd37ec0a16b5685872924b1.png)
![nelfc](https://www.amplemarketreports.com/uploads/310aacf1a5791dcb27a830435cfd4a05.jpg)
![UCDAVIS](https://www.amplemarketreports.com/uploads/c6be6089bdfb066c78e9a58b818ed359.png)
![Doosan](https://www.amplemarketreports.com/uploads/7eb0559d9b233077f9b6f00c7af01554.png)
![Huntsman](https://www.amplemarketreports.com/uploads/be59db7d240f744739d9384a5abd8256.png)
![Bioiberica](https://www.amplemarketreports.com/uploads/c000716182ee50c7400108d735137a8f.jpg)
![Apponboard](https://www.amplemarketreports.com/uploads/2fd65f30451e84dee0685f7081acdde3.png)
![Lazada Group](https://www.amplemarketreports.com/uploads/ae37d02b49e9962db6dc72b36c993c23.png)
![aksys](https://www.amplemarketreports.com/uploads/eb8b44c562bd87739c6c8b8b666e4409.png)
![Honeywell](https://www.amplemarketreports.com/uploads/c6784763001e7e0f1283b6080b3d2036.png)
![XTREMAX](https://www.amplemarketreports.com/uploads/77c43842d2a21eefdcd18962861cb0fc.png)